Optimal Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.82M Hold
88,766
0.48% 67
2021
Q2
$3.48M Hold
88,766
0.41% 82
2021
Q1
$3.22M Buy
88,766
+11,400
+15% +$405K 0.42% 75
2020
Q4
$2.85M Sell
77,366
-4,178
-5% -$153K 0.4% 74
2020
Q3
$2.84M Buy
81,544
+7,263
+10% +$255K 0.41% 71
2020
Q2
$2.31M Sell
74,281
-32,626
-31% -$1.11M 0.37% 90
2020
Q1
$3.31K Buy
106,907
+64,215
+150% +$2.19M 0.31% 103
2019
Q4
$1.59M Buy
+42,692
New +$1.52M 0.24% 161

Other funds holding PFE

Optimal Asset Management's PFE Position: Q3 2021 in Review

Optimal Asset Management held its Pfizer (PFE) position steady in Q3 2021 at 88,766 shares worth $3.82M. The position accounts for 0.48% of the portfolio, ranked #67.

Optimal Asset Management first reported a position in PFE in Q4 2019 and has held it in 8 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Optimal Asset Management held 88,766 shares of Pfizer worth $3.82M as of Q3 2021.
  • Optimal Asset Management left its Pfizer share count unchanged in Q3 2021.
  • Pfizer made up 0.48% of Optimal Asset Management's portfolio in Q3 2021, its #67 holding.
  • Optimal Asset Management first reported a position in Pfizer in Q4 2019 and has held it in 8 quarters since.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.